BIOTIME INC Separation Agreements
3 Contracts & Agreements
- Separation Agreement dated July 5, 2022, between Lineage Cell Therapeutics, Inc. and Kevin L. Cook (Filed With SEC on July 7, 2022)
- Asset Contribution and Separation Agreement, dated August 17, 2017, between BioTime, Inc. and AgeX Therapeutics, Inc (Filed With SEC on November 9, 2017)
- Separation Agreement, as of March 10, 2016, between Pedro Lichtinger and Asterias Biotherapeutics, Inc (Filed With SEC on May 10, 2016)
